Detall de l'activitat

XIVth Congress Catalan Society of Immunology (SCI). Joint meeting with European Federation of Immunological Societies on Tour (EFIS on TOUR)
Societat Catalana d'Immunologia
Dies 19 i 20 de novembre de 2020 | Online
19-11-2020 | 15:30 - 20:15 | Online
15:30 - 16:00Arrival, Registration and Documentation delivery ( Lliurament de la documentació )
16:00 - 16:15Welcome to the XIVth CONGRESS of the SCI ( Sessió )
Presentador/a: Dr. Marcos López Hoyos. President of the SEI
Presentador/a: Dr. Ricardo Pujol Borrell. President of the SCI
16:15 - 17:00Opening Lecture – ( Sessió )
Immunological memory against the dogma
Moderador/a: Dr. Pablo Engel Rocamora. University of Barcelona
Ponent: Dr. Andreas Radbruch. Charité, Universitätsmedizin Berlin
17:00 - 17:30Poster viewing ( Sessió )
17:30 - 18:00Plenary Session: Inter-TCR crosstalk during antigen recognition. ( Sessió )
Moderador/a: Dra. Annabel Valledor. University of Barcelona
Ponent: Dr. Balbino Alarcón. Centro Biología Molecular Severo Ochoa, Madrid
18:00 - 19:45Oral Communications, Session-1 – Basic and Experimental Immunology ( Sessió )
Moderador/a: Dr. Winfried Pickl. Medical University of Vienna
Experimental and genetic evidence for the involvement of CD6 in inflammatory bowel diseases.
Ponent: Dr. Sergi Casadó Llombar. et al.
Macrophage mitochondrial MFN2 (mitofusin 2) links immune stress and immune response through reactive oxygen species (ROS) production
Ponent: Dr. Antonio Celada. et al.
Immunomodulation of type 1 diabetes by 116C-NOD intestinal microbiota
Ponent: Dra. Estela Rosell Mases. et al.
siRNA-containing transfection of vitamin D3-induced tolerogenic dendriticcells for the silencing of potential tolerogenic genes
Ponent: Dr. Íñigo González Larreategui. et al.
Immunomodulatory properties of a soluble cytomegalovirus-encoded CD48 Homolog.
Ponent: Dr. Francesc Poblador. et al.
MRL mice infected with cytomegalovirus (CMV) as an animal model of Sjögren’s Syndrome.
Ponent: Dr. Joan Puñet Ortiz. et al.
HIV-1 enveloped Virus-Like Particles (VLP) displaying high density of HIV-1 Env-derived antigens on their surface induce a functional immune response beyond neutralizing activity
Ponent: Dr. Ferran Tarrés Freixas. et al.
19:25 - 19:45Discussion (Oral Communications, Session-1 – Basic and Experimental Immunology) ( Sessió )
19:45 - 20:15Plenary Session: The role of a new T helper cell type, Th-IL-2 cells, in allergic immune reactions ( Sessió )
Moderador/a: Dra. Eva Maria Martinez Carceres. Autonomus University of Barcelona
Ponent: Dr. Winfried Pickl. Medical University of Vienna
20-11-2020 | 08:30 - 20:00 | Online
08:30 - 09:00Arrival, Registration and Documentation delivery ( Sessió )
09:00 - 09:30Plenary Session: Tissue memory cells at the center of the immune system ( Sessió )
Moderador/a: Dra. Dolores Jaraquemada Perez de Guzmán. Autonomous University of Barcelona
Ponent: Dr. René Van Lier. Sanquin Blood Supply. University of Amsterdam
09:30 - 10:00Plenary Session: Development of humen “adaptive” NK cell populations: open issues. ( Sessió )
Moderador/a: Dr. Miguel López Botet. University Pompeu Fabra, Barcelona
Moderador/a: Dr. Pablo Engel Rocamora. University of Barcelona
10:00 - 11:30Oral Communications, Session 2: Clinical Immunology I ( Sessió comunicacions )
Moderador/a: Dra. Cristina Costa Vallès. (IDIBELL, Barcelona
Moderador/a: Dra. Mª Rosa Faner Canet. Hospital Clinic, Barcelona
Changes induced in lymphocyte subpopulations by dimethyl-fumarate treatment in multiple sclerosis could identify “NEDA” patients.
Ponent: Dra. Aina Teniente Serra. et al.
Lymphocyte subpopulations analysis in psoriatic patients treated with biological drugs
Ponent: Dr. Marc Boigues Pons. et al.
Myeloid-Derived Suppressor Cells in Kidney Transplant Recipients and the effect of Maintenance Immunotherapy
Ponent: Dra. María Iglesias Escudero. et al.
Pretransplant adaptive NKG2C+ NK cells protect against cytomegalovirus infection in kidney transplant recipients
Ponent: Dra. Michelle Ataya. et al.
Impaired lung NK activity in the lung of Idiopathic Pulmonary Fibrosis patients
Ponent: Dra. Tamara Cruz. et al.
Immunophenotype in CU patients under omalizumab treatment.
Ponent: Dra. Cristina Alejandra López Rodriguez
11:30 - 12:00Plenary Session: Conventional and unconventional T cell response to microbial antigens. ( Sessió )
Moderador/a: Dr. Ricardo Pujol Borrell. Autonomous University of Barcelona
Ponent: Dra. Federica Sallusto. Institute for Research in Biomedicine Bellinzona
12:00 - 13:00Ordinary General Meeting- Societat Catalana d’Immunologia ( Sessió )
13:00 - 13:30Poster viewing ( Sessió comunicacions )
13:30 - 14:00Lunch session sponsored by Becton Dickinson.Resolving immune cell identity one cell at time. The multiomic approach. ( Càtering )
Ponent: Dr. Werner Rodriguez. BD Biosciences | Single Cell Multiomics
14:30 - 16:15Oral Communications, Session 3: Tumor Immunology and Immunotherapy ( Sessió comunicacions )
Moderador/a: Dr. Manel Juan Otero. Hospital Clinic. Barcelona
Phase I multicenter clinical trial with chimeric antigen receptor with humanized anti-BCMA specific ( ARI0002h) in patients with relapsed or refractory multiple myeloma
Ponent: Dra. Mariona Pascal Capdevila. et al.
CART19-BE-01: un ensayo académico Europeo sobre la administración de células CAR-T denominadas ARI-0001 en pacientes con trastornos linfoproliferativos CD19+.
Ponent: Dr. Valentín Ortiz Maldonado. et al.
Humoral immune response in patients with CD19 positive relapsed/refractory B-cell malignances recruited into the CART19-BE-01 clinical trial
Ponent: Dra. Ariadna Bartoló Ibars. et al.
Comparative analysis and characterization of TCR repertoires in breast cancer TILs
Ponent: Dra. Andrea Aran Garriga. et al.
HAVCR2 mutations altering TIM-3 underlying hemophagocytic syndrome and subcutaneous panniculitis-like T-cell lymphoma.
Ponent: Dr. Roger Colobran Oriol. et al.
Dynamics of T-cell subsets in non-small cell lung cancer patients treated with PD-1/PD-L1 axis blocking mAbs
Ponent: Dra. Coral Zurera Egea. et al.
NK cell receptors and ligand variants modulate response to tyrosine kinaseinhibitors in patients with chronic myeloid leukemia
Ponent: Dra. Laia Closa Gil. et al.
15:55 - 16:15Discussion (Oral Communications, Session 3: Tumor Immunology and Immunotherapy) ( Sessió )
16:15 - 16:45Plenary Session: Unconventional receptor-based antibodies ( Sessió )
Moderador/a: Dr. Miguel López Botet. (University Pompeu Fabra , Barcelona
Ponent: Dr. Antonio Lanzavecchia. National Institute of Molecular Genetics, Milan
16:45 - 18:00Oral Communications, Session 4: COVID-19 ( Sessió comunicacions )
Moderador/a: Dra. Silvia Vidal Alcorisa. Santa Creu i Sant Pau Hospital, Barcelona
Early S2-targeting and rapid development of neutralizing antibodies after SARS-CoV-2 infection.
Moderador/a: Dra. Maria Luisa Rodriguez de la Concepción. et al.
Antigen-specific lymphocyte proliferation against SARS-CoV-2 in COVID patients with negative antibodies against the virus in serum
Ponent: Dra. Marc Boigues Pons. et al.
Immunological Risk Profile in COVID-19, the Experience of a Single Academic Hospital in Catalonia.
Ponent: Dr. Manuel Hernández González . et al.
Immunopathogenesis of COVID-19-related pediatric inflammatory multisystem syndrome: overlap with Kawasaki disease and identification of a distinct severe group
Ponent: Dra. Ana Esteve Solé. et al.
Revealing protective T cell immune responses against SARS-CoV-2.
Ponent: Dra. Judith Grau Expósito. et al.
Inborn errors and autoantibodies against type-I inteferons in patients with life-threatening COVID-19.
Ponent: Dr. Roger Colobran Oriol. et al.
17:45 - 18:00Discussion.(Oral Communications, Session 4: COVID-19) ( Sessió )
18:00 - 18:15Prize to the best communication and poster ( Sessió )
Ponent: Dr. Ricardo Pujol Borrell. (President of SCI
18:15 - 18:30Closing of the Congress ( Sessió cloenda )
Presentador/a: Dr. Ricardo Pujol Borrell. (President of SCI